HOME >> BIOLOGY >> NEWS
Acupuncture versus acid reflux: 40% cut in sphincter relaxations brings hope for relief

BETHESDA, Md. (August 30, 2005) Even the U.S. National Institutes of Health doesn't know what causes gastroesophageal reflux disease, or GERD. And NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) says there's an unclear relationship between GERD, heartburn and hiatal hernia (HH). Patients may have only one out of three, any two out of three, or all three.

Nevertheless, clinicians know that all three often occur together and that a variety of lifestyle changes, medication, surgery and recently approved devices and an implant are imperfect solutions.

An encounter between a Taiwanese gastroenterologist wanting to study acupuncture and an opening at the Royal Adelaide Hospital resulted in two experiments looking into how the traditional Eastern approach might affect transient lower esophageal sphincter relaxations (TLESRs). Since TLESRs are "the most important mechanism of acid reflux in normal subjects and patients with GERD," they were targeted for study.

The paper describing the study, "Inhibition of transient lower esophageal sphincter relaxations by electrical acupoint stimulation," appears in the August issue of the American Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society. Research was performed by Duowu Zou, Wei Hao Chen, Katsuhiko Iwakiri, Rachael Rigda, Marcus Tippett and Richard H. Holloway of the Royal Adelaide Hospital, Australia.

The Neiguan connection

"It was an out-of-left-field approach, without any real expectations that it might work," according to Richard H. Holloway, in whose Royal Adelaide Hospital laboratory the work was done, "but we had well-defined technology and measurements for studying GERD." The protocol utilized electrical acupoint stimulation, a high-tech type of acupuncture, with a GERD model imposed on normal subjects by inflating a balloon in their stomachs.

In two separate studies, barely
'"/>


30-Aug-2005


Page: 1 2 3 4

Related biology news :

1. Prediction of graft-versus-host disease by gene-expression profiling of donors and more
2. Preventing graft-versus-host disease disease after bone marrow transplant -- without toxicity
3. Risk/benefit analysis of farmed versus wild salmon
4. Sex versus survival: A tradeoff at geographical range limits
5. Coke versus Pepsi: Its all in the head
6. MIT study: Maturity brings richer memories
7. Variant CJD -- Prion amplification breakthrough brings new insights and hopes for a blood test
8. Extracting eggs from pre-pubertal cancer patients brings hope for future fertility
9. Dilbert of academia brings humor to talk at UH
10. Disorderly protein brings order to cell division
11. $1 million Myers Fellowship brings US research techniques to Melbourne

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)...  There is much more to innovative access systems ... Continental will demonstrate the intelligence of today,s solutions at ... Through the combination of the keyless entry and start ... the international technology company is opening up new possibilities ... "The integration of biometric elements brings our expertise ...
Breaking Biology News(10 mins):
(Date:1/19/2017)... and GAITHERSBURG, Md. ... MKT: PIP) and Altimmune, Inc., a privately-held immunotherapeutics ... of a definitive agreement for the merger of ... current investors include Novartis Venture Fund, HealthCap, Truffle ... be a fully-integrated and diversified immunotherapeutics company with ...
(Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
(Date:1/19/2017)... Ca (PRWEB) , ... January 18, 2017 , ... ... events for tech innovators, engineers, and scientists from around the world, was today ... News. The awards program is based entirely on merit and decided upon by ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... services spanning the full spectrum of drug and device development, and Prism ... pharma/device companies and clinicians, today announced Verified Clinical Trials (VCT) has ...
Breaking Biology Technology:
Cached News: